Strategic Developments in Polymer-Functionalized Liposomes for Targeted Colon Cancer Therapy: An Updated Review of Clinical Trial Data and Future Horizons

S Sharma, M Chakraborty, D Yadav, A Dhullap… - …, 2024 - ACS Publications
Liposomes, made up of phospholipid bilayers, are efficient nanocarriers for drug delivery
because they can encapsulate both hydrophilic and lipophilic drugs. Conventional cancer …

The Use of Lipid-based Nanocarriers to Improve Ovarian Cancer Treatment: An Overview of Recent Developments

J Tantray, A Patel, BG Prajapati, S Kosey… - Current …, 2024 - benthamdirect.com
Ovarian cancer poses a formidable health challenge for women globally, necessitating
innovative therapeutic approaches. This review provides a succinct summary of the current …

Formulation, optimization and characterization of raloxifene hydrochloride loaded PLGA nanoparticles by using Taguchi design for breast cancer application

B Maddiboyina, H Roy, RK Nakkala… - Chemical Biology & …, 2023 - Wiley Online Library
Multidrug resistance in breast cancer and the associated side‐effects of anticancer therapies
are significant hurdles in chemotherapy‐based treatment. Biodegradable polymeric nano …

Novel Drug Delivery Systems in Colorectal Cancer: Advances and Future Prospects

A Awasthi, P Paul, MS Mir, SK Singh, K Dua - Pathology-Research and …, 2024 - Elsevier
Colorectal cancer (CRC) is an abnormal proliferation of cells within the colon and rectum,
leading to the formation of polyps and disruption of mucosal functions. The disease …

Response surface methodology for an improved nanoemulsion of ivacaftor & its optimisation for solubility and stability

A Parihar, BG Prajapati - Pharmacophore, 2023 - pharmacophorejournal.com
Cystic fibrosis is caused by a mutation in the gene located on chromosome 7's extended arm
and is also an autosomal recessive disease. A protein regulates chloride ion transport …